Copyright 201x | Duplication of this product and its content in print or digital form for the purpose
of sharing with others is prohibited without permission from PICMET.
A single link to the first track to allow the export script to build the search page
Technology Management Framework
Drug Development Abandonment Stage for Japanese Pharmaceutical Companies
- Hiromi Saito, Chiba University ;
- Koichi Sumikura, National Graduate Institute for Policy Studies
Use this link to view the PDF file: Drug Development Abandonment Stage for Japanese Pharmaceutical Companies